News by subject: HEALTH

January 31, 2023 Latest innovation has the potential to reduce anesthesia during minimally invasive procedures [1] As a pioneer and leading innovator in cardiac ultrasound, Philips has developed the smaller X11- 4t Mini 3D TEE transducer to...

Biogen Inc. today announced plans to reprioritize its resources in Alzheimer's disease (AD), a strategic therapeutic area expected to drive near and long-term growth. The company will...

Zymeworks Inc. , a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced that management will participate in the...

January 30, 2024, London, UK ? OPEN Health has launched OPEN X Health, a new practice focused on providing data-driven creativity to the pharmaceutical industry. OPEN X Health (OPEN X) launches after two years of investment and growth in the...

    January 29, 2024 Delivers strong sales growth, improved profitability, and strong cash flow in 2023 through solid execution of first year of 2023-2025 planAgrees with FDA on terms of consent decree focused on Philips...

PharmAla Biotech Holdings Inc. ("PharmAla" or the "Company") , a biotechnology company focused on the research, development, and manufacturing of LaNeotm MDMA and novel derivatives of MDMA (MDXX class molecules), is pleased to announce that it has...

Kane Biotech Inc. (the "Company" or "Kane Biotech" or "Kane") today announces that the Company will be presenting its revyvetm Antimicrobial Wound Gel at the Boswick Burn and Wound Care Symposium. The international conference will take place from...

TVO Today releases The Ultimate Choice, a groundbreaking original podcast series that explores the state of Medical Assistance in Dying (MAID) in Canada, developed in partnership with the Investigative Journalism Bureau (IJB) and the Toronto Star....

Organovo Holdings, Inc. , a clinical stage biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis, based on demonstration of clinical promise in three-dimensional (3D) human tissues, today...

TerrAscend Corp. ("TerrAscend" or the "Company") , a leading North American cannabis company, today announced the expansion of its Valhalla product offering to include one of the first 100mg edibles in The Keystone State. Valhalla's 100mg...

The EmpowerHER Leadership Network proudly unveils its innovative networking platform, marking a transformative milestone in championing and supporting women within Canadian health care. Designed collaboratively by Jennifer Stewart, President and CEO...

Celiac patients in hospitals and long-term care residents who cannot advocate for themselves are often served food containing gluten, which can lead to horrendous symptoms and even death if they're fed unsafe food for long enough. Tiny amounts of...

The Alberta Cancer Foundation is thrilled to announce that Entos Pharmaceuticals (Entos) and 48Hour Discovery are the first recipients of its new Breakthrough Fund, an innovative, philanthropic vehicle that will support important research...

Biognosys, a leader in next-generation proteomics solutions for drug...

Diabetes Canada is proud to announce the winners of its End Diabetes Awards, an annual competition that aims to dramatically improve the lives of people living with or at risk of type 1 and type 2 diabetes through innovative research. Each research...

Aligning with the powerful message of the "#BellLetsTalk" campaign, Money Mentors joins the conversation with "Let's Talk About Debt". This initiative focuses on breaking the stigma surrounding debt, acknowledging its profound impact on mental...

January 22, 2024, London, UK ? OPEN Health is pleased to announce the appointment of Steven Duryee as Chief Operating and Transformation Officer. In this role, Steve will be responsible for the execution of the strategic plan, large-scale...

Biomimetic Innovations Ltd today announced that OsStic® has been granted ?Breakthrough Device' designation by the FDA. The proposed indication statement for this novel new technology is: "OsStic® Synthetic Injectable Bone Void Filler is a...

Optimi Health Corp. (FRA: 8BN) ("Optimi" or the "Company"), a Health Canada licensed drug researcher and formulator specializing in controlled psychedelic substances such as natural psilocybin and MDMA, is pleased to announce it has been granted an...

A triple-demic of flu, RSV and COVID has left patients facing some of the worst wait times ever for emergency care, while health workers experience appalling working conditions. Time is running out to address this crisis, warned President of the...

The Canadian Men's Health Foundation (CMHF) is helping more men tackle chronic stress, anxiety and depression with the MindFit Toolkit, presented by TELUS Health. In 2023, the number of virtual counselling sessions completed by men increased by 13...

Pizza Nova has donated $15,000 to the SickKids Foundation as part of its holiday fundraiser, featuring the sale of its 60th anniversary commemorative tote bag online and in stores. The bag featured the brand's iconic "Ciao" greeting with a portion of...

NurExone Biologic Inc. (NRX.V) (the "Company" or "NurExone"), a biopharmaceutical company developing biologically-guided exosome therapy for patients with traumatic spinal cord injuries, is pleased to share several updates. The collaborative...

Jack.org, a leading Canadian youth mental health charity, and presenting sponsor Bank of America, are kicking off the 15th anniversary Jack Ride ? a cycling event held each spring to raise urgently needed support for young people's mental health....

January is Alzheimer's Awareness Month, recognised across Canada and internationally as an opportunity to reflect on the challenges faced by the growing number of people living with dementia, and their care partners. To underscore the urgency of this...

Bow Valley College and partner Calgary Region Immigrant Employment Council (CRIEC) have received a $9.4 million grant from the Government of Canada to help Internationally Educated Nurses (IENs) gain employment in Canada.  Employment and Social...

Who says eating healthy has to be boring? The Chopped Leaf is here to spice up your new year and help you achieve your 2024 healthy-eating goals like never before. The star of the show is The Chopped Leaf's fan-favorite Bangkok Bowl, which is...

NetworkNewsAudio ? Lexaria Bioscience Corp. announces the availability of a broadcast titled, "Exciting New Cures Possible from GLP-1 Diabetes, Weight-Loss Drugs." To hear the AudioPressRelease, please visit: The NetworkNewsAudio News Podcast To...

Salona Global Medical Device Corporation (the ???"Company") ??, announced today it has executed an exclusive distribution agreement with Veteran Medical Solutions, LLC ("VMS"), a U.S. military veteran owned company that is positioned to sell the...

First published randomized controlled trial for market-leading implant demonstrates impressive outcomes for rotator cuff tears                Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces...

Today, TELUS Health, a global leader in health technology, and Clinia, a leading provider of health-grade search technologies have announced an exclusive strategic partnership to revolutionize...

LifeLabs is proud to announce our achievement for the second consecutive year ? securing the 2024 BrandSpark Most Trusted Brand Award in Health Diagnostic Services. "In the ever-evolving landscape of healthcare, this back-to-back win is a...

via InvestorWire ? Lexaria Bioscience Corp. today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 60+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), a specialized communications platform...

Organovo Holdings, Inc. , a clinical stage biotechnology company that is focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human...

The ABILITY-1 Study will evaluate MDNA11, a highly selective long-acting IL-2 Superkine, in combination with KEYTRUDA® (pembrolizumab) for treatment of patients with advanced solid tumorsMDNA11 continues to demonstrate encouraging single-agent...

LSL Pharma Group Inc. ? (the "Company" or "LSL Pharma Group"), a Canadian integrated pharmaceutical company, announces that it extends until February 7, 2024 its brokered private placement through the issuance of unsecured convertible debentures at...

Recursion , a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced it has signed an agreement with Bayer AG to in-license a new chemical entity that emerged from the companies' fibrosis research...

Knight Therapeutics Inc., ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today the launch of IMVEXXY® in Canada. IMVEXXY® (estradiol vaginal inserts) is approved for the treatment of postmenopausal moderate to severe...

Preliminary total 4Q and full year 2023 net product revenue of $71 million and $204 million, respectively Auvelity preliminary 4Q and full year 2023 net product sales of $49 million and $130 million, respectively Sunosi preliminary 4Q and full year...

Company well-positioned for further progress and broadening of R&D pipelineCash resources of approximately $455 million as of December 31, 2023 (unaudited)Expected cash runway, including proceeds from recent private placement, into 2H 2027Top-line...

Zymeworks Inc. , a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today...

Adagene Inc. ("Adagene") , a company transforming the discovery and development of novel antibody-based therapies, today announced a poster presentation...

Calgary Health Foundation Board Vice Chair Sarah Kennedy has been appointed as Interim Board Chair. Sarah has been a dedicated member of the Board for 11 years, providing thoughtful leadership as Vice Chair over the past four years. "We are...

Optimi Health Corp. (FRA: 8BN) ("Optimi"), a Health Canada licensed drug researcher and formulator specializing in controlled psychedelic substances such as natural psilocybin and MDMA, proudly announces a significant milestone in the granting of...

HydroGraph Clean Power Inc. (the "Company" or "HydroGraph"), a commercial manufacturer of high-quality nanomaterials, announced today that its flagship graphene product, FGA-1, has been successfully trialed in Hawkeye Bio's biomedical sensor aimed...

OBI Pharma, a clinical stage oncology company (4174.TWO), today announced that the U.S. Food and Drug Administration (FDA) has cleared an investigational new drug (IND) application for OBI-992, to conduct a Phase 1/2 study of its novel antibody -...

A diagnosis of dementia is not easy. During National Alzheimer's Awareness Month in January, the ALZHEIMER SOCIETY OF ALBERTA AND NORTHWEST TERRITORIES connects people living with dementia and their care partners with free support, knowledge, and a...

Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the...

Trogarzo® IM maintenance dosing aims to further enhance the convenience of non-oral therapy for heavily treatment-experienced adults with HIV Submission comes on the heels of the recent FDA approval of the Trogarzo® IV push loading dose    This news...

Cell BioEngines, Inc., a clinical-stage biotechnology company focused on delivering novel, innovative stem cell and immune cell therapies to address blood and solid cancers, today announced an agreement with Miltenyi to develop and manufacture its...